ArticleCancer immunology, immunotherapy : CII2014

Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity.

Valentina Rigo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.